GNF2133
Catalog No.
BA8905
GNF2133 is a potent, selective, and orally active inhibitor of DYRK1A and GSK3β at 0.0062, >50μM, respectively.
Featured Products
GNF2133 is a potent, selective, and orally active inhibitor of DYRK1A and GSK3β at 0.0062, >50μM, respectively.GNF2133 has good proliferative capacity and efficacy on rat and human primary β-cells.GNF2133 significantly enhances glucose handling and increases insulin secretion.GNF2133 has research type 1 diabetes.
| Physical Appearance | A solid |
| Storage | -20°C |
| M.Wt | 434.53 |
| Cas No. | 2561414-56-8 |
| Formula | C24H30N6O2 |
| Chemical Name | 4-ethyl-N-(4-(1-(tetrahydro-2H-pyran-4-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl)pyridin-2-yl)piperazine-1-carboxamide |
| Canonical SMILES | O=C(N1CCN(CC)CC1)NC2=NC=CC(C3=CN(C4=CN=CC=C43)C5CCOCC5)=C2 |
| Shipping Condition | Small Molecules with Blue Ice, Modified Nucleotides with Dry Ice. |
| General tips | We do not recommend long-term storage for the solution, please use it up soon. |
Quality Control & MSDS
- View current batch:
Chemical structure
